Transcriptional atlas of cardiogenesis maps congenital heart disease interactome.

Autor: Li X; Division of Biomedical Statistics and Informatics, Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota;, Martinez-Fernandez A; Division of Cardiovascular Diseases, Department of Medicine, Mayo Clinic, Rochester, Minnesota;, Hartjes KA; Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, Minnesota;, Kocher JP; Division of Biomedical Statistics and Informatics, Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota;, Olson TM; Division of Cardiovascular Diseases, Department of Medicine, Mayo Clinic, Rochester, Minnesota; Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, Minnesota; Division of Pediatric Cardiology, Department of Pediatric and Adolescent Medicine, Mayo Clinic, Rochester, Minnesota; Center for Regenerative Medicine, Mayo Clinic, Rochester, Minnesota;, Terzic A; Division of Cardiovascular Diseases, Department of Medicine, Mayo Clinic, Rochester, Minnesota; Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, Minnesota; Center for Regenerative Medicine, Mayo Clinic, Rochester, Minnesota;, Nelson TJ; Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, Minnesota; Division of Pediatric Cardiology, Department of Pediatric and Adolescent Medicine, Mayo Clinic, Rochester, Minnesota; Center for Regenerative Medicine, Mayo Clinic, Rochester, Minnesota; Transplant Center, Mayo Clinic, Rochester, Minnesota; and Division of General Internal Medicine, Department of Medicine, Mayo Clinic, Rochester, Minnesota nelson.timothy@mayo.edu.

Publikováno v: Physiological genomics [Physiol Genomics] 2014 Jul 01; Vol. 46 (13), pp. 482-95. Date of Electronic Publication: 2014 May 06.

Natural cardiogenesis-based template predicts cardiogenic potential of induced pluripotent stem cell lines.

Autor: Martinez-Fernandez A; Division of Cardiovascular Diseases, Department of Medicine, Department of Molecular Pharmacology and Experimental Therapeutics, Division of General Internal Medicine Transplant Center, Division of Biomedical Statistics and Informatics, and Center for Regenerative Medicine, Mayo Clinic, Rochester, MN., Li X, Hartjes KA, Terzic A, Nelson TJ

Publikováno v: Circulation. Cardiovascular genetics [Circ Cardiovasc Genet] 2013 Oct; Vol. 6 (5), pp. 462-71. Date of Electronic Publication: 2013 Sep 14.

Apoptotic susceptibility to DNA damage of pluripotent stem cells facilitates pharmacologic purging of teratoma risk.

Autor: Smith AJ; Department of Medicine and Transplant Center, Mayo Clinic, Rochester, MN 55905, USA., Nelson NG, Oommen S, Hartjes KA, Folmes CD, Terzic A, Nelson TJ

Publikováno v: Stem cells translational medicine [Stem Cells Transl Med] 2012 Oct; Vol. 1 (10), pp. 709-18. Date of Electronic Publication: 2012 Sep 27.

Induced pluripotent stem cells from GMP-grade hematopoietic progenitor cells and mononuclear myeloid cells.

Autor: Ohmine S; Department of Molecular Medicine, College of Medicine, Mayo Clinic, Rochester, MN 55905, USA., Dietz AB, Deeds MC, Hartjes KA, Miller DR, Thatava T, Sakuma T, Kudva YC, Ikeda Y

Publikováno v: Stem cell research & therapy [Stem Cell Res Ther] 2011 Nov 16; Vol. 2 (6), pp. 46. Date of Electronic Publication: 2011 Nov 16.